Boston Implements GLP-1 Coverage Restrictions for City Employees

The administration in Boston plans to implement restrictions on the coverage of GLP-1 weight loss drugs and some other medications for city employees and retirees. This initiative aims to save approximately $11 million in response to budget constraints. Officials cite an increase in healthcare expenses, partly due to the rising use of GLP-1 treatments among city workers, driving both Massachusetts state officials and private insurers nationwide to reevaluate coverage of these costly medications.

An agreement with the Public Employee Committee (PEC), representing unionized city employees and retirees, aims to limit coverage of non-specialty drugs. This includes GLP-1 medications. The PEC unanimously approved changes to the Blue Cross Blue Shield of Massachusetts health plan to incorporate "utilization management." Effective July 1, this mechanism requires prior authorization for specific prescriptions, reducing the chances of employee approval for GLP-1 drug coverage.

Mayor Michelle Wu highlighted this measure as crucial for managing rising expenses while maintaining essential healthcare coverage and city services. A joint statement from Wu and PEC chair Elissa Cadillic emphasized responsible cost management. Cadillic noted that a portion of the savings, estimated at $1 million, will support Boston Public Schools. The rest, between $8 million and $9 million, will aim to prevent staff layoffs and service cuts, with additional savings offsetting employee premium increases.

Without these changes, employees on the city's Blue Cross Blue Shield family plans could see premiums jump from $655 to $803. The agreement instead results in a 20 percent increase, raising costs to $788. The city also plans to negotiate a new five-year health insurance contract by June, with the current agreement expiring on July 1, 2027.

The Boston Firefighters Union Local 718 backed the agreement, acknowledging the city's effort to reinvest in its workforce. Sam Dillon, union president, stressed the importance of maintaining reasonable healthcare costs while preparing for future challenges. Similarly, Erik Berg, president of the Boston Teachers Union, praised the compromise for preventing premium hikes, maintaining drug coverage, and avoiding layoffs.

City Councilor Sharon Durkan, who benefits from GLP-1 medication through the city's insurance plan, stated that the agreement reflects the city's fiscal responsibility while ensuring access to necessary treatments. Boston's budget for health-related benefits this fiscal year is $483 million, covering 55,000 employees, families, and retirees.

Ashley Groffenberger, Boston's chief financial officer, warned that premiums would significantly rise without intervention. By enforcing prior authorization for GLP-1 medications, the city expects to save between $8 million and $9 million. Meanwhile, Massachusetts' Group Insurance Commission recently halted GLP-1 drug coverage for state employees for similar fiscal reasons. Similar actions are underway in states like North Carolina, California, and New Hampshire.